With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...
The biotech company plans to move into the new development in 2028, consolidating other leased and owned spaces in the ...
Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...
MANILA, Philippines — The Department of Trade and Industry (DTI) said on Friday that it has an investment pipeline worth at least $76 billion (around P4 trillion), signaling a strong outlook for ...
CAMBRIDGE, MA, USA I March 11, 2025 I Biogen Inc. (Nasdaq: BIIB ... Felzartamab is a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of ...
(Ukrainian Emergency Service via AP) LONDON — Russian special forces walked inside a gas pipeline to strike Ukrainian units from the rear in the Kursk region, Ukraine’s military and Russian ...
Russian special forces crept through a disused gas pipeline for several miles to launch a surprise attack on Ukrainian soldiers in the Kursk region, Ukraine's military and pro-Moscow war bloggers ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
More Stanislav Krasilnikov / Sputnik via AP Ukraine's armed forces shared footage late on Saturday that it said showed its soldiers attacking elite Russian forces "moving along a gas pipeline ...
Biogen and Ionis Pharmaceuticals’ Spinraza could be on the US market within weeks after a phase 3 trial in the rare neuromuscular disorder, spinal muscular atrophy, met its goal. The ...
A small Swiss biotech has terminated a mid-stage test of a new type of oral drug for people with Alzheimer’s disease, according to the federal … ...
Biogen/Eisai’s LEQEMBI (lecanemab) Overview LEQEMBI, developed by Biogen and Eisai, is a humanized IgG1 monoclonal antibody targeting both soluble aggregated forms (protofibrils) and insoluble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback